Chemocentryx (CCXI)

Add to Watchlists Create an Alert
5.49 -0.15  -2.66% NASDAQ Jul 28, 8:00PM BATS Real time Currency in USD
View Full Chart
CCXI Price Chart
View All Events

CCXI Events

Date Type Description
08/05/2014 17:00 EDT Misc Chemocentryx Inc Q2 2014 Earnings Conference Call
08/05/2014 Earnings Chemocentryx Inc Q2 2014 Earnings Results. Estimate: -0.27.
05/22/2014 Misc Annual General Meeting for Chemocentryx Inc
05/08/2014 17:00 EDT Misc Q1 2014 Chemocentryx Inc Earnings Conference Call
05/08/2014 Earnings Q1 2014 Chemocentryx Inc Earnings Results. Estimate: -0.24.
03/13/2014 17:00 EDT Misc Chemocentryx Inc Q4 2013 Earning Conference Call
03/13/2014 Earnings Chemocentryx Inc Q4 2013 Earning Result. Estimate: -0.24.
11/07/2013 17:00 EST Misc Chemocentryx, Inc. To Hold Third Quarter 2013 Financial Results Conference Call on Thursday, November 7, 2013
11/07/2013 Earnings Chemocentryx, Inc. To Release Third Quarter 2013 Financial Results. Estimate: -0.26.
08/12/2013 17:00 EDT Misc Chemocentryx, Inc. To Hold Second Quarter 2013 Financial Results Conference Call on Monday, August 12, 2013
View All Performance Charts

CCXI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Chemocentryx is down 60.84% over the last year vs S&P 500 Total Return up 19.54%, Dynavax Technologies up 8.73%, and Arrowhead Research up 265.5%.

Get Quote for
Advertisement

Portfolio Strategies Featuring CCXI

Did Chemocentryx make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CCXI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.chemocentryx.com
  • IR Website: http://ir.chemocentryx.com/
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry: Scientific Research and Development Services
  • NAICS Sector: Professional, Scientific, and Technical Services

Chemocentryx Inc is a biopharmaceutical company engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.

CCXI Excel Add-In Codes

  • Name: =YCI("CCXI","name")
  • Description: =YCI("CCXI","description")
  • Sector: =YCI("CCXI","sector")
  • Industry: =YCI("CCXI","industry")
  • Est. Current Fiscal Year End: =YCI("CCXI","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.